tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 968 are a BUY (93.26%), 67 are a HOLD (6.45%), 3 are a SELL (0.29%).
Analyst Raghuram Selvaraju, currently employed at HC WAINWRIGHT, carries an average stock price target met ratio of 33.16% that have a potential upside of 47.09% achieved within 173 days.
Raghuram Selvaraju’s has documented 1,945 price targets and ratings displayed on 110 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on AXSM, Axsome Therapeutics at 07-May-2025.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for EVOK (EVOKE PHARMA) at 7/18/2016. The price target of $288 was fulfilled within 3 days with a profit of $128.16 (30.8%) receiving and performance score of 102.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
10 months 25 days ago
(18-Jun-2024)
18/47 (38.3%)
$6.81 (213.48%)
538
Sell
1 years 5 months 23 days ago
(19-Nov-2023)
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-9.41 (-90.39%)
$5
1 years 6 months 18 days ago
(25-Oct-2023)
3/21 (14.29%)
$0.29 (40.85%)
40
Sell
$1
$-9.41 (-90.39%)
$3.5
1 years 9 months 24 days ago
(19-Jul-2023)
10/12 (83.33%)
$-0.08 (-7.41%)
347
Hold
$1.25
$-9.16 (-87.99%)
$2
1 years 9 months 24 days ago
(19-Jul-2023)
2/5 (40%)
$0.17 (15.74%)
215
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
